Literature DB >> 20717099

Tolerance: an overview and perspectives.

Herman Waldmann1.   

Abstract

Self tolerance is dependent on mechanisms that operate on T cells and B cells from the earliest stages, that is, from when they first express anti-self-receptors in the primary lymphoid organs of the thymus and bone marrow, all the way through to when they engage with self antigens in the peripheral immune system and within tissues themselves. This continuum of checkpoints and fail-safes ensures that the risk of developing harmful autoimmune diseases remains very small. Certain tissues have a degree of privilege that allows them to mute the immune response against them by mechanisms that are also well represented in cancers. An understanding of the underlying mechanisms of self tolerance is hoped to spawn a new range of therapeutics designed to both reprogram the immune system to avoid long-term intense immunosuppression, and to override the immune system to achieve more effective immunity against cancers and persistent viral infections.

Entities:  

Mesh:

Year:  2010        PMID: 20717099     DOI: 10.1038/nrneph.2010.108

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  102 in total

1.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

Review 3.  Transgenic models of T-cell self tolerance and autoimmunity.

Authors:  J F Miller; G Morahan; R Slattery; J Allison
Journal:  Immunol Rev       Date:  1990-12       Impact factor: 12.988

4.  Induction of immune tolerance by administration of monoclonal antibody to L3T4.

Authors:  N L Gutstein; W E Seaman; J H Scott; D Wofsy
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

5.  Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice.

Authors:  E Adams; A Basten; C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Induction of tolerance by monoclonal antibody therapy.

Authors:  R J Benjamin; H Waldmann
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

7.  Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms.

Authors:  I E Van den Herik-Oudijk; P J Capel; T van der Bruggen; J G Van de Winkel
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

8.  Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation.

Authors:  Stephen F Yates; Alison M Paterson; Kathleen F Nolan; Stephen P Cobbold; Nigel J Saunders; Herman Waldmann; Paul J Fairchild
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

9.  Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes.

Authors:  J F Miller; G F Mitchell
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

10.  Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

Authors:  Alasdair J Coles; D Alastair S Compston; Krzysztof W Selmaj; Stephen L Lake; Susan Moran; David H Margolin; Kim Norris; P K Tandon
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

View more
  14 in total

Review 1.  Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation.

Authors:  Urvashi Kaundal; Upma Bagai; Aruna Rakha
Journal:  J Transl Med       Date:  2018-02-15       Impact factor: 5.531

Review 2.  Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.

Authors:  Leo Luznik; Paul V O'Donnell; Ephraim J Fuchs
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

Review 3.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

Review 4.  The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

Authors:  Kenneth R Cooke; Leo Luznik; Stefanie Sarantopoulos; Frances T Hakim; Madan Jagasia; Daniel H Fowler; Marcel R M van den Brink; John A Hansen; Robertson Parkman; David B Miklos; Paul J Martin; Sophie Paczesny; Georgia Vogelsang; Steven Pavletic; Jerome Ritz; Kirk R Schultz; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-03       Impact factor: 5.742

5.  Good news-bad news: the Yin and Yang of immune privilege in the eye.

Authors:  John V Forrester; Heping Xu
Journal:  Front Immunol       Date:  2012-11-27       Impact factor: 7.561

6.  Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein.

Authors:  Qiaohong Meng; Wenfeng Wang; Xiaowen Shi; Yongfeng Jin; Yaozhou Zhang
Journal:  Clin Dev Immunol       Date:  2011-06-06

7.  A common biomarker signature for tolerated allografts and self tissues.

Authors:  Alain Le Moine; Nick D Jones
Journal:  Front Immunol       Date:  2011-05-04       Impact factor: 7.561

8.  Killer B lymphocytes and their fas ligand positive exosomes as inducers of immune tolerance.

Authors:  Steven K Lundy; Matthew W Klinker; David A Fox
Journal:  Front Immunol       Date:  2015-03-20       Impact factor: 7.561

9.  Hematopoietic chimerism and transplantation tolerance: a role for regulatory T cells.

Authors:  Lise Pasquet; Olivier Joffre; Thibault Santolaria; Joost P M van Meerwijk
Journal:  Front Immunol       Date:  2011-12-28       Impact factor: 7.561

10.  The cholinergic anti-inflammatory pathway delays TLR-induced skin allograft rejection in mice: cholinergic pathway modulates alloreactivity.

Authors:  Claude Sadis; Sophie Detienne; Benoît Vokaer; Louis-Marie Charbonnier; Philippe Lemaître; Chloé Spilleboudt; Sandrine Delbauve; Carole Kubjak; Véronique Flamand; Kenneth A Field; Michel Goldman; Fleur S Benghiat; Alain Le Moine
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.